Novel Bcl-2 Inhibitors Selectively Disrupt the Autophagy-Specific Bcl-2-Beclin 1 Protein-Protein Interaction. 2022

Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.

Autophagy plays essential roles in a wide variety of physiological processes, such as cellular homeostasis, metabolism, development, differentiation, and immunity. Selective pharmacological modulation of autophagy is considered a valuable potential therapeutic approach to treat diverse human diseases. However, development of such therapies has been greatly impeded by the lack of specific small molecule autophagy modulators. Here, we performed structure-activity relationship studies on a previously discovered weak Bcl-2 inhibitor SW076956, and developed a panel of small molecule compounds that selectively released Bcl-2-mediated inhibition of autophagy-related Beclin 1 compared to apoptosis-related Bax at nanomolar concentration. Our NMR analysis showed that compound 35 directly binds Bcl-2 and specifically inhibits the interaction between the Bcl-2 and Beclin 1 BH3 domains without disruption of the Bcl-2-Bax BH3 interaction. More broadly, this proof-of-concept study demonstrates that targeting protein-protein interactions of the intrinsic autophagy regulatory network can serve as a valuable strategy for the development of autophagy-based therapeutics.

UI MeSH Term Description Entries

Related Publications

Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
January 2019, Advances in experimental medicine and biology,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
September 2005, Cell,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
July 2012, Cells,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
May 2020, Journal of the American Chemical Society,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
November 2010, Autophagy,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
June 2021, Folia parasitologica,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
November 2010, Autophagy,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
January 2012, American journal of cancer research,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
December 2008, Oncogene,
Xiaonan Dong, and Qiren Liang, and Yun-Zu Pan, and Xiaoyu Wang, and Yi-Chun Kuo, and Wei-Chung Chiang, and Xuewu Zhang, and Noelle S Williams, and Josep Rizo, and Beth Levine, and Jef K De Brabander
January 2007, Autophagy,
Copied contents to your clipboard!